Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnosis of Myeloproliferative Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00361140
What this trial is testing

Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT)

Who this might be right for
Myelodysplastic SyndromesMyeloproliferative DisordersLeukemia, Lymphocytic+2 more
H. Lee Moffitt Cancer Center and Research Institute 72
Large-scale testing (Phase 3)Study completedNCT01743989
What this trial is testing

Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML.

Who this might be right for
Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
Novartis Pharmaceuticals 620
Early research (Phase 1)Study completedNCT00246662
What this trial is testing

Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Nonlymphocytic, AcuteLeukemia, Myeloid, Chronic+1 more
Sunesis Pharmaceuticals 75
Testing effectiveness (Phase 2)Study completedNCT00719888
What this trial is testing

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+16 more
Fred Hutchinson Cancer Center 135
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Not applicableLooking for participantsNCT01890486
What this trial is testing

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+7 more
Wake Forest University Health Sciences 2,000
Testing effectiveness (Phase 2)UnknownNCT01133886
What this trial is testing

Use of Decitabine in Myelodysplastic Syndrome (MDS) Following Azacitidine (AZA) Failure

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome
King's College London 50
Not applicableStudy completedNCT05611216
What this trial is testing

Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 164
Testing effectiveness (Phase 2)Study completedNCT00003735
What this trial is testing

Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 11
Large-scale testing (Phase 3)Ended earlyNCT00967343
What this trial is testing

Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor

Who this might be right for
Myeloid LeukemiaLymphoblastic LeukemiaLymphoma+3 more
Kiadis Pharma 40
Early research (Phase 1)Study completedNCT00070538
What this trial is testing

VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Vion Pharmaceuticals
Not applicableUnknownNCT04525768
What this trial is testing

Gastroesophageal Varices in Cavernoma

Who this might be right for
Gastroesophageal VaricesMyeloproliferative NeoplasmPortal Caver Cavernoma+1 more
Shanghai Zhongshan Hospital 80
Testing effectiveness (Phase 2)Ended earlyNCT03922100
What this trial is testing

Study of NMS-03592088 in Patients With Relapsed or Refractory AML or CMML

Who this might be right for
Acute Myeloid Leukemia (AML)Chronic Myelomonocytic Leukemia (CMML)
Nerviano Medical Sciences 63
Testing effectiveness (Phase 2)Study completedNCT00745550
What this trial is testing

Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis

Who this might be right for
MyelofibrosisMyeloproliferative DisordersPolycythemia Vera+1 more
S*BIO 55
Early research (Phase 1)UnknownNCT05074550
What this trial is testing

Safety Evaluation Study for Patients With Polycythemia Vera

Who this might be right for
Polycythemia Vera
Perseus Proteomics Inc. 6
Testing effectiveness (Phase 2)Study completedNCT01019317
What this trial is testing

Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
LeukemiaAMLMDS+1 more
M.D. Anderson Cancer Center 151
Not applicableUnknownNCT02380378
What this trial is testing

Registry of Philadelphia-Negative Myeloproliferative Neoplasms

Who this might be right for
Hematologic Diseases
Hospital Israelita Albert Einstein 500
Early research (Phase 1)Looking for participantsNCT05304377
What this trial is testing

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid LeukemiaChronic Phase Chronic Myeloid Leukemia, BCR-ABL1 PositiveCml
Enliven Therapeutics 250
Testing effectiveness (Phase 2)Ended earlyNCT00428077
What this trial is testing

Vaccine Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
OHSU Knight Cancer Institute 4
Testing effectiveness (Phase 2)Ended earlyNCT00818649
What this trial is testing

Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndrome
Masonic Cancer Center, University of Minnesota 16
Next Page